EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Polydeoxyribonucleotide as a Biotherapy for Musculoskeletal Disorders

Jaeseok Choi, Yeong-Min Yoo iD

International Journal of Molecular Sciences · 16.08.2026 · 27 (16) · 7304

DOI: 10.3390/ijms27167304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.08.2026. Verfasst von Jaeseok Choi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Environmental Research, Kangwon National University, Chuncheon 24341, Republic of Korea. Hauptthemen laut MEDLINE: Polydeoxyribonucleotides, Musculoskeletal Diseases, Biological Therapy. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polydeoxyribonucleotide (PDRN) is a DNA-derived biological therapy gaining prominence in the treatment of musculoskeletal disorders. It functions as an adenosine A2A receptor (A2AR) agonist and serves as a substrate in the nucleotide salvage pathway. These mechanisms drive anti-inflammatory effects, stimulate angiogenesis via vascular endothelial growth factor, and promote collagen synthesis. In osteoarthritis, PDRN reduces cartilage degradation and promotes the chondrogenic differentiation of stem cells. PDRN has shown therapeutic potential in tendinopathies, including Achilles and rotator cuff injuries, by supporting tissue repair. Preliminary reports suggest it may offer a non-steroidal alternative for managing spinal radiculopathy when corticosteroids are contraindicated, though robust comparative trials are needed. Preclinical and clinical evidence indicate favorable preliminary safety profiles and potential pain reduction. Future large-scale trials are needed to standardize the dosing protocols for integrated orthopedic rehabilitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolydeoxyribonucleotidesMusculoskeletal DiseasesBiological TherapyHumansAnimals

Stichwörter der Autor:innen

adenosine A2A receptormusculoskeletal disordersorthopedic rehabilitationpolydeoxyribonucleotidespinal radiculopathytendinopathies

Substanzen

Polydeoxyribonucleotides

Autor:innen und Institutionen

  • Institute of Environmental Research, Kangwon National University, Chuncheon 24341, Republic of Korea.

ORCID-Profile: Yeong-Min Yoo

Zitieren

APA

Choi, J., & Yoo, Y. M. (2026). The Role of Polydeoxyribonucleotide as a Biotherapy for Musculoskeletal Disorders. International Journal of Molecular Sciences, 27(16), 7304. https://doi.org/10.3390/ijms27167304

Vancouver

Choi J, Yoo YM. The Role of Polydeoxyribonucleotide as a Biotherapy for Musculoskeletal Disorders. International Journal of Molecular Sciences. 2026;27(16):7304. doi:10.3390/ijms27167304

BibTeX
@article{Choi2026,
  author = {Choi, Jaeseok and Yoo, Yeong-Min},
  title = {The Role of Polydeoxyribonucleotide as a Biotherapy for Musculoskeletal Disorders},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7304},
  doi = {10.3390/ijms27167304}
}
Kostenlos starten →